Summary
Dr. Inigo San Millan discusses his research connecting zone 2 training, mitochondrial function, and cancer metabolism. He explains how skeletal muscle acts as an endocrine organ during exercise, releasing exosomes containing microRNAs and proteins that travel through the bloodstream and can suppress tumor growth -- making regular exercise a direct anti-cancer intervention. San Millan describes his groundbreaking lactate oncometabolite hypothesis, initially rejected seven or eight times before publication, which now has over 850 citations. The research shows that lactate regulates the genetic expression of major cancer genes, connecting the Warburg effect to broader mitochondrial dysfunction. The conversation also covers data from indigenous populations in the Bolivian Amazon who exercise 115-135 minutes daily and have less than 1% rates of type 2 diabetes, compared to 60-65% chronic disease rates in Western societies. San Millan explains how the talk test closely matches laboratory lactate measurements for identifying zone 2 intensity.
Key Points
- Skeletal muscle is an endocrine organ that releases exosomes during exercise -- vesicles containing microRNAs and proteins that travel through the bloodstream and can suppress tumor growth
- The lactate oncometabolite hypothesis shows lactate regulates the genetic expression of major cancer genes, connecting the Warburg effect to mitochondrial dysfunction
- Indigenous populations exercising 115-135 minutes daily have less than 1% rates of type 2 diabetes versus 60-65% chronic disease in Western societies
- The talk test closely matches laboratory lactate measurements for zone 2 intensity -- you should be able to sustain a conversation but with noticeable effort
- Zone 2 training combined with high-intensity sessions two or more times per week hits the metabolic sweet spot for health
- Lactate is a master regulator for carcinogenesis and a preferred cellular fuel source, not a waste product
Key Moments
Skeletal muscle as an anti-cancer endocrine organ
San Millan explains how skeletal muscle releases exosomes during exercise -- vesicles containing miRNAs and proteins that travel through the bloodstream and can suppress tumor growth, making exercise a direct anti-cancer intervention.
"but it's also these exosomes can also have an effect on stage 3 cancer outcomes. That's fascinating. I would love to know more about that research because it's really fascinating. And as you know, exosomes from skeletal muscle can cross our blood-brain barrier, right? And there's a whole new area there to understand relating not just to cancer, but other diseases like type 2 diabetes and the connection with Alzheimer's as well."
Lactate as an oncometabolite in cancer biology
San Millan describes his groundbreaking research showing lactate regulates the genetic expression of major cancer genes, connecting the Warburg effect to his broader work on mitochondrial dysfunction.
"Yeah. So lactate, let's talk about that because I know it's a big part of your research and lactate is often misunderstood. We went through this phenomenon. I don't know how you felt about this phenomenon of people saying that it's the lactic acid burning your quads. That's what it is. And we now know that that's a myth. It's been debunked. But-"
Hunter-gatherer populations and metabolic disease
San Millan discusses research on indigenous populations in the Bolivian Amazon who exercise 115-135 minutes daily and have less than 1% rates of type 2 diabetes, compared to 60-65% chronic disease rates in Western societies.
"Well, I think new ideas are usually hard to don't have much of a room with an NIH scope, right? You know, the high risk, high reward, you know, we all talk about, I mean, it's very, we know that high risk, high rewarding in research should be quite important, but for NIH, it's only 0.5% of the total budget per year. So it's hard for, you know,"
Zone 2 as the talk test intensity
San Millan explains that the talk test closely matches what laboratory lactate measurements show for zone 2 intensity -- you should be able to sustain a conversation but with noticeable effort.
"Well, I think new ideas are usually hard to don't have much of a room with an NIH scope, right? You know, the high risk, high reward, you know, we all talk about, I mean, it's very, we know that high risk, high rewarding in research should be quite important, but for NIH, it's only 0.5% of the total budget per year. So it's hard for, you know,"
